125 related articles for article (PubMed ID: 30469507)
1. Orthosteric and/or Allosteric Binding of α-Conotoxins to Nicotinic Acetylcholine Receptors and Their Models.
Kryukova EV; Ivanov IA; Lebedev DS; Spirova EN; Egorova NS; Zouridakis M; Kasheverov IE; Tzartos SJ; Tsetlin VI
Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30469507
[TBL] [Abstract][Full Text] [Related]
2. αO-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human α9α10 subtype.
Zhangsun D; Zhu X; Kaas Q; Wu Y; Craik DJ; McIntosh JM; Luo S
Neuropharmacology; 2017 Dec; 127():243-252. PubMed ID: 28416445
[TBL] [Abstract][Full Text] [Related]
3. Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors.
Huynh PN; Harvey PJ; Gajewiak J; Craik DJ; Michael McIntosh J
Biochem Pharmacol; 2020 Nov; 181():114124. PubMed ID: 32593612
[TBL] [Abstract][Full Text] [Related]
4. Selective Penicillamine Substitution Enables Development of a Potent Analgesic Peptide that Acts through a Non-Opioid-Based Mechanism.
Gajewiak J; Christensen SB; Dowell C; Hararah F; Fisher F; Huynh PN; Olivera BM; McIntosh JM
J Med Chem; 2021 Jul; 64(13):9271-9278. PubMed ID: 34142837
[TBL] [Abstract][Full Text] [Related]
5. Alpha9 nicotinic acetylcholine receptors and the treatment of pain.
McIntosh JM; Absalom N; Chebib M; Elgoyhen AB; Vincler M
Biochem Pharmacol; 2009 Oct; 78(7):693-702. PubMed ID: 19477168
[TBL] [Abstract][Full Text] [Related]
6. Potency- and Selectivity-Enhancing Mutations of Conotoxins for Nicotinic Acetylcholine Receptors Can Be Predicted Using Accurate Free-Energy Calculations.
Katz D; DiMattia MA; Sindhikara D; Li H; Abraham N; Leffler AE
Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34202022
[TBL] [Abstract][Full Text] [Related]
7. Structural determinants of selective alpha-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP.
Ulens C; Hogg RC; Celie PH; Bertrand D; Tsetlin V; Smit AB; Sixma TK
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3615-20. PubMed ID: 16505382
[TBL] [Abstract][Full Text] [Related]
8. Ribbon α-Conotoxin KTM Exhibits Potent Inhibition of Nicotinic Acetylcholine Receptors.
Marquart LA; Turner MW; Warner LR; King MD; Groome JR; McDougal OM
Mar Drugs; 2019 Nov; 17(12):. PubMed ID: 31795126
[TBL] [Abstract][Full Text] [Related]
9. Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads.
Armishaw CJ
Toxins (Basel); 2010 Jun; 2(6):1471-99. PubMed ID: 22069647
[TBL] [Abstract][Full Text] [Related]
10. Computational and Functional Mapping of Human and Rat α6β4 Nicotinic Acetylcholine Receptors Reveals Species-Specific Ligand-Binding Motifs.
Hone AJ; Kaas Q; Kearns I; Hararah F; Gajewiak J; Christensen S; Craik DJ; McIntosh JM
J Med Chem; 2021 Feb; 64(3):1685-1700. PubMed ID: 33523678
[TBL] [Abstract][Full Text] [Related]
11. Effects of Cyclization on Activity and Stability of α-Conotoxin TxIB.
Li X; Wang S; Zhu X; Zhangsun D; Wu Y; Luo S
Mar Drugs; 2020 Mar; 18(4):. PubMed ID: 32235388
[TBL] [Abstract][Full Text] [Related]
12. Rational Design of Potent α-Conotoxin PeIA Analogues with Non-Natural Amino Acids for the Inhibition of Human α9α10 Nicotinic Acetylcholine Receptors.
Li T; Tae HS; Liang J; Zhang Z; Li X; Jiang T; Adams DJ; Yu R
Mar Drugs; 2024 Feb; 22(3):. PubMed ID: 38535451
[TBL] [Abstract][Full Text] [Related]
13. Structure-Function of Neuronal Nicotinic Acetylcholine Receptor Inhibitors Derived From Natural Toxins.
Ho TNT; Abraham N; Lewis RJ
Front Neurosci; 2020; 14():609005. PubMed ID: 33324158
[TBL] [Abstract][Full Text] [Related]
14. Total synthesis of pinnatoxins A and G and revision of the mode of action of pinnatoxin A.
Araoz R; Servent D; Molgó J; Iorga BI; Fruchart-Gaillard C; Benoit E; Gu Z; Stivala C; Zakarian A
J Am Chem Soc; 2011 Jul; 133(27):10499-511. PubMed ID: 21644584
[TBL] [Abstract][Full Text] [Related]
15. Posttranslational modifications of α-conotoxins: sulfotyrosine and C-terminal amidation stabilise structures and increase acetylcholine receptor binding.
Ho TNT; Lee HS; Swaminathan S; Goodwin L; Rai N; Ushay B; Lewis RJ; Rosengren KJ; Conibear AC
RSC Med Chem; 2021 Sep; 12(9):1574-1584. PubMed ID: 34671739
[TBL] [Abstract][Full Text] [Related]
16. Fifty Years of Animal Toxin Research at the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS.
Tsetlin V; Shelukhina I; Kozlov S; Kasheverov I
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762187
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic Acetylcholine Receptors Are Novel Targets of APETx-like Toxins from the Sea Anemone
Kalina RS; Kasheverov IE; Koshelev SG; Sintsova OV; Peigneur S; Pinheiro-Junior EL; Popov RS; Chausova VE; Monastyrnaya MM; Dmitrenok PS; Isaeva MP; Tytgat J; Kozlov SA; Kozlovskaya EP; Leychenko EV; Gladkikh IN
Toxins (Basel); 2022 Oct; 14(10):. PubMed ID: 36287966
[TBL] [Abstract][Full Text] [Related]
18. The α9α10 nicotinic acetylcholine receptor: a compelling drug target for hearing loss?
Elgoyhen AB
Expert Opin Ther Targets; 2022 Mar; 26(3):291-302. PubMed ID: 35225139
[TBL] [Abstract][Full Text] [Related]
19. Marine Origin Ligands of Nicotinic Receptors: Low Molecular Compounds, Peptides and Proteins for Fundamental Research and Practical Applications.
Kasheverov I; Kudryavtsev D; Shelukhina I; Nikolaev G; Utkin Y; Tsetlin V
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204690
[TBL] [Abstract][Full Text] [Related]
20. Biomedical Potential of the Neglected Molluscivorous and Vermivorous
Zhao Y; Antunes A
Mar Drugs; 2022 Jan; 20(2):. PubMed ID: 35200635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
